Is Tesofensine Safe for Managing Mood? (TRT Q&As)
Timeline
Dr. O’Connor explains that tesofensine is an investigational agent that affects serotonin, noradrenaline, and dopamine and has been researched for obesity and other conditions. Because it is not an approved medication with an established safety profile, he urges caution and discusses established antidepressant medications as better-studied alternatives for mood symptoms.
A 53-year-old man reports suppression after using SARMs along with erectile and blood pressure concerns. Dr. O’Connor emphasizes that recovery primarily takes time and discusses the potential role of PCT approaches involving HCG and medications such as Clomid or tamoxifen while warning that SARMs can suppress natural testosterone production.
A 29-year-old man who has been on TRT for four years after prohormone-related suppression reports mediocre libido, acne, testosterone levels that remain below 600, and depressive symptoms from even tiny doses of anastrozole. Dr. O’Connor says the case is complex, raises SHBG as one factor to investigate, and notes that the member is currently off TRT while pursuing fertility treatment.
Dr. O’Connor discusses coming off the steroids, allowing time to see whether natural testosterone production recovers, and potentially using PCT. He cautions that severe depression or suicidal thoughts during withdrawal require immediate medical attention and says some men who remain profoundly suppressed may ultimately need testosterone.
Dr. O’Connor explains that ordinary testosterone replacement does not generally have a meaningful direct effect on endogenous cortisol. He distinguishes the testosterone and adrenal hormonal systems while noting that stress and elevated cortisol can influence natural testosterone production.
A 23-year-old man reports significant weight loss and problems with testosterone after previously using a testosterone-boosting product. Dr. O’Connor focuses on his elevated SHBG, explaining that it can bind more testosterone and leave free testosterone low despite the total testosterone result, and says TRT may eventually be considered after a complete health evaluation.
Video Summary
This mailbag discussion focuses on questions about balancing symptom improvement with laboratory stability during testosterone therapy. It explains that symptom relief and lab optimization do not always move in perfect alignment. Balance is framed as a process requiring context rather than precision targeting.
A central portion discusses how lab markers and reported symptoms should be weighed together over time. The episode emphasizes avoiding overcorrection when one measure appears out of range in isolation. Proportional interpretation is highlighted to support stable outcomes.
The closing segment reinforces testosterone therapy as long-term clinical care. Ongoing monitoring, patience, and expectation alignment are emphasized. Hormone therapy is positioned as benefiting from balance rather than continual adjustment.
Drug Callouts
Condition Callouts
Key Takeaways
- Symptoms and labs should be interpreted together.
- Perfect alignment is not always achievable.
- Overcorrection can reduce stability.
- Balance supports long-term outcomes.
- Proportional interpretation improves care quality.